Showing results (1611-1620 of 4,521) with videos related to
Sort By:
Pageof 453
Future Oncology (London, England)|February 14, 2019
Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?Martin Reck, Keith M Kerr, Christian Grohé, et al.Future Oncology (London, England)|March 25, 2006
Cancer biomarkers: knowing the present and predicting the futureSabarni K Chatterjee, Bruce R ZetterFuture Oncology (London, England)|March 25, 2006
The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neckJames S Norris, Kristi L Norris, David H Holman, et al.Future Oncology (London, England)|March 25, 2006
Race, gender and mutations in the prediction of anti-EGFR activityAntonio JimenoFuture Oncology (London, England)|March 25, 2006
Therapeutic potential of EGFR-related protein, a universal EGFR family antagonistAdhip P N MajumdarFuture Oncology (London, England)|March 25, 2006
Cytochrome P450 1B1: a novel anticancer therapeutic targetMorag C E McFadyen, Graeme I MurrayFuture Oncology (London, England)|March 25, 2006
Docetaxel for the treatment of prostate cancerD C Gilbert, C ParkerFuture Oncology (London, England)|March 25, 2006
Can targeting apoptosis resolve the cancer saga?Zodwa Dlamini, Zukile Mbita, Thokozile LedwabaFuture Oncology (London, England)|March 25, 2006
Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancerRichard F Riedel, Phillip G FebboPageof 453